MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202641083231 A) filed by Dr. Ohmini Krishnamurthy Rajendran on July 07, 2026, for Artificial Intelligence–powered Smart Oncoscope Platform For Continuous Multimodal Cancer Monitoring, Treatment Toxicity Prediction, And Adaptive Therapeutic Response Prediction.
Inventor includes Dr. Ohmini Krishnamurthy Rajendran.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to the development of the platform which combines wearables, physiological monitors, medical imaging, lab markers, patient’s electronic health records, genome, and patient-reported outcomes into an intelligent framework. Advanced artificial intelligence and machine learning techniques are used to analyze multimodal data in real-time to identify the development of disease, predict toxicity of treatment, determine efficacy of the therapy and produce personalized risk scores. Predictive models are updated based on dynamic information about patients for providing personalized treatments. Data analytics and data management in cloud technology are used for remote monitoring, clinicians’ decision-making and personalized cancer management. The proposed solution will improve detection of disease development, minimize risks of adverse events and maximize patient’s benefits. FIG.1
Disclaimer: Curated by HT Syndication.
